Bayer’s consensus analyst price target has risen modestly from €28.71 to €29.57, indicating a slight increase in confidence regarding the company’s fair value. This upward adjustment comes as revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback